Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates.
J Craig Ruble, Alexander R Hurd, Timothy A Johnson, Debra A Sherry, Michael R Barbachyn, Peter L Toogood, Gordon L Bundy, David R Graber, Gregg M Kamilar
文献索引：J. Am. Chem. Soc. 131(11) , 3991-7, (2009)
全文：HTML全文
摘要
PNU-286607 is the first member of a promising, novel class of antibacterial agents that act by inhibiting bacterial DNA gyrase, a target of clinical significance. Importantly, PNU-286607 displays little cross-resistance with marketed antibacterial agents and is active against methicillin-resistant staphylococcus aureus (MRSA) and fluoroquinoline-resistant bacterial strains. Despite the apparent stereochemical complexity of this unique spirocyclic barbituric acid compound, the racemic core is accessible by a two-step route employing a relatively obscure rearrangement of vinyl anilines, known in the literature as the "tert-amino effect." After a full investigation of the stereochemical course of the racemic reaction, starting with the meso cis-dimethylmorpholine, a practical asymmetric variant of this process was developed.
相关化合物
相关文献：
The preparation of some polymethine astrazon dyes. Gale DJ and Wilshire JFK.
[Aust. J. Chem. 23(5) , 1063-68, (1970)]
Novel synthesis of dibenzo [b,g] 1, 5-oxazocines. Ouyang X and Kiselyov AS.
[Tetrahedron Lett. 40(32) , 5827-30, (1999)]
Facile solid phase synthesis of 1, 2-disubstituted-6-nitro-1, 4-dihydroquinazolines using a tetrafunctional scaffold. Wang X MLA, et al.
[Tetrahedron Lett. 46(3) , 427-30, (2005)]
A valuable heterocyclic ring transformation: from isoxazolin-5 (2H)-ones to quinolines. Abbiati G, et al.
[Tetrahedron 59(50) , 9887-93, (2003)]